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Role of Genetic Counselors in Prenatal Zika Care

Abstract:
Zika virus (ZIKV) was first identified in 1945 in Uganda’s Zika forest. The 2015 Brazil
outbreak identified the ZIKV as a teratogen, leading to a heightened awareness in prenatal care
in the United States. ZIKV is primarily transmitted via mosquitoes; however, vertical
transmission from mother to fetus has also been reported. Intrauterine fetal infection is associated
with Congenital Zika Syndrome, characterized by severe microcephaly with loss of brain tissue,
macular atrophy, postnatal hypertonia and limited joint movements. Given their expertise in
prenatal education and teratogen counseling, genetic counselors (GCs) may be uniquely suited to
provide prenatal ZIKV care. Our goal was to assess the role of GCs in prenatal ZIKV care. A
survey was distributed to practicing GCs through the National Society of Genetic Counselor’s
member listserv. The survey focused on the GCs’ knowledge of ZIKV care, comfort providing
ZIKV counseling, their current role in their institution, and their opinion on the role of a GC in
prenatal ZIKV care. Other demographics were collected to investigate other possible
correlations. The study showed that GCs with experience in providing ZIKV counseling were
more comfortable providing prenatal ZIKV care. However, this comfort did not correlate with
their tested knowledge.

Key words: Zika Virus, Congenital Zika Syndrome, Genetic Counselors, Microcephaly,
Teratogen, Prenatal
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Introduction
Virus discovery and migration
Zika virus (ZIKV) was first identified in 1945 in Uganda’s Zika forest. In April 1947,
Dick GW et al isolated ZIKV from feverish sentinel rhesus macaque (Macaca mulatta) while
collecting data for a serosurvey of the area for Yellow Fever (Dick, 1952; Faizan et al., 2017).
Antibodies against ZIKV were found among residents with no evidence of the disease. In 1953,
MacNamara reported the first human ZIKV infection in three patients in Nigeria (1954). The
virus then spread to the Yap Islands in 2007 affecting approximately 73% of the island’s
inhabitants. This was followed by the outbreak in French Polynesia in 2013-2014, where it was
first correlated with neurological problems in newborns and Guillain-Barré syndrome in adults
(Besnard, Lastere, Teissier, Cao-Lormeau, & Musso, 2014). GBS is an autoimmune disorder
affecting the myelin sheath of the peripheral nervous system, impairing the muscle-brain
neuronal signals (“Guillain-Barré Syndrome Fact Sheet | National Institute of Neurological
Disorders and Stroke,” n.d.).
In 2014, the Va’a World Sprint Championship canoe race held in Rio de Janerio marked
the entry of the ZIKV to Brazil (Musso, 2015) resulting in 1.3 million suspected cases. By
October 2015, the disease had spread to Columbia with 65,338 suspected ZIKV cases by April
2016. By January 12, 2017, ZIKV infections were documented in 48 different Pan American
countries and territories(Yun & Lee, 2017). From 2015 to March 20, 2018, 2,286 laboratory
tested pregnancies were reported to have possible ZIKV infection in the United States. Of these
laboratory tested pregnancies, 114 liveborn infants were affected by a ZIKV associated birth
defect(s) and 9 resulted in pregnancy loss related to ZIKV associated birth defects (“Pregnancy
Outcomes | Zika and Pregnancy | CDC,” n.d.).
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Transmission
The primary vectors transmitting the ZIKV are the Aedes mosquitoes (Frankel, Pandya,
Gersch, Siddiqui, & Schneider, 2017). Gilda Grard et al highlighted that amongst the mosquitoes
that carry ZIKV, only those of the Aedes genus were seen to infect humans. Although, Aedes
hensilli and Aedes polynesiensis were associated with the Yap and French Polynesian outbreaks
(Duffy et al., 2009); Aedes aegypti and Aedes albopictus, native to Africa and Asia respectively,
were involved in the 2015 – 2016 outbreaks in the Americas (Grard et al., 2014).
ZIKV can also be transmitted through sexual contact and prenatally from mother to fetus.
The virus has been detected in other bodily fluids such as breast milk, blood, saliva, vaginal
secretions, and respiratory droplets, but transmission of the virus through these fluids is still
under investigation (Besnard et al., 2014; Darwish, Hoogstraal, Roberts, Ahmed, & Omar, 1983;
Dick, 1952; Kilbourn et al., 2001). Foy et al was first to report sexual transmission of ZIKV
infection in 2008, followed by another study by Musso et al in Tahiti reporting the presence of
ZIKV particles in human semen. The virus survives longer in sperm with high copy number of
the viral RNA longer than 62 days after the onset of symptoms (Foy et al., 2011; Musso et al.,
2015). However, it is unclear how viral shedding takes place within both male and female
reproductive tracts and associated fluids. ZIKV shedding may occur in phases, which may result
in a false negative test due to the virus shedding at a later period of time (“Exposure, Testing
&amp; Risks | Zika and Pregnancy | CDC,” n.d.). Several studies have reported the vertical
transmission of the ZIKV from infected mothers to fetuses during pregnancy. Miner et al
isolated ZIKV from placental trophoblasts suggesting trans-placental infection. Melo et al and
Calvet et al identified the presence of ZIKV using reverse transcription polymerase chain
reaction (RT-PCR) in the amniotic fluid of fetuses with microcephalic heads on the ultrasound.
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ZIKV has been identified in brain and placental tissues of affected fetuses as well as tissue
samples of infected products of conception (Calvet et al., 2016; Miner et al., 2016; Oliveira Melo
et al., 2016).
Clinical Symptoms
Clinical symptoms associated with a ZIKV infection include fever, fatigue, myalgia,
headache, rashes, conjunctivitis, retro-orbital pain (Faizan et al., 2017), and arthralgias (Brasil et
al., 2016). There have also been reports of genitourinary symptoms (hematospermia, hematuria,
perineal pain and prostatitis) and digestive tract symptoms (nausea, diarrhoea and aphthous
ulcers of the mouth) (Foy et al., 2011; Ioos, Goffart, Gauthier, Cardoso, & Herida, 2014;
Moloney, Kmush, Rudolph, Cummings, & Lessler, 2014; “Symptoms | Zika virus | CDC,” n.d.).
Clinical symptoms arise after the incubation period, usually last up to 2 weeks and 80% of
infected individuals are asymptomatic or with mild symptoms (Duffy et al., 2009). The World
Health Organization (WHO) reported an increase in the incidence of GBS and congenital
microcephaly in 13 countries and territories with ZIKV outbreaks (2017).
Congenital Zika Syndrome
A teratogen is a foreign element that can disturb the normal development of an embryo or
fetus. Its harmful effects vary based on the type of teratogen, the gestational age at the time of
exposure and the dose and duration of exposure (Recommendations, 2017). ZIKV belongs to the
flaviviridae family and its molecular structure is similar to dengue and chikungunya viruses of
this family. It utilizes humans, monkeys and mosquitoes as hosts for replication (“ArboCat
Virus: Zika (ZIKAV),” n.d.).
Sonja A. Rasmussen et al compared the documented clinical symptoms to both Shepard
and Bradford Hill’s teratogenic criteria and further supported the association of prenatal ZIKV
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infections and congenital abnormalities (2016). After the outbreak in Brazil, the predicted risk
for developing Congenital Zika Syndrome (CZS) was estimated as 1-13%. A study showed that
11% of the fetuses exhibited signs of congenital abnormalities when infected within the first
trimester (Honein et al., 2017), which is the time frame for fetal neurological development. In
multiple human cases, traces of the ZIKV were found in the placenta and amniotic fluid of
fetuses with microcephaly. When human cortical neural progenitor cells were induced with the
ZIKV, they were susceptible to ZIKV infection, thus supporting its neurotropic nature. It is
believed that the infection affects the regulation of key facilitating genes for autophagy and
apoptosis resulting in neural degradation and/or impairment (Faizan et al., 2017; Cugola1 et al.,
2016; Tang et al., 2016).
Studies show fetal abnormalities can occur regardless of the gestational age at the time of
ZIKV exposure or severity of maternal symptoms. Case reports from the USA show that 15% of
first trimester infections resulted in birth defects (Reynolds et al., 2017). While data from US
territories, show ZIKV infection resulted in 8%, 5% and 4% birth defects in the first, second and
third trimester respectively (Shapiro-Mendoza et al., 2017). Reynolds et al. also reported that in
the USA, 8% of symptomatic and 12% of asymptomatic women had babies with birth defects.
However, Sharpiro et al reported that in US territories 5% of symptomatic and 7% of
asymptomatic women had babies with birth defects.
ZIKV infection causes fetal growth restriction, microcephaly, malformations of the brain
and central nervous system, polyhydramnios, placental insufficiency, miscarriages and
intrauterine fetal demise later in the pregnancy (Bayer et al., 2016; Martines et al., 2016; Mlakar
et al., 2016). CZS is characterized by severe microcephaly with loss of brain tissue, macular
atrophy, severe postnatal hypertonia and limited joint movements such as clubfoot (“Birth
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Defects | Zika virus | CDC,” n.d.). Neonates with CZS might also present with low-birth weight,
redundant scalp skin, arthrogryposis, swallowing difficulties, neurological (cerebral lesions,
brainstem dysfunction, polymalformation syndrome) and ophthalmic (cataract, asymmetrical
eyes, intraocular calcifications optic nerve hypoplasia, lens subluxation) abnormalities. The
correlation between ZIKV and microcephaly, observed during the outbreaks in French Polynesia
and Brazil, raises concerns for infections during the first trimester (Cauchemez et al., 2016; de
Araújo et al., 2016; Jouannic, Friszer, Leparc-Goffart, Garel, & Eyrolle-Guignot, 2016). Soares
de Souza et al studied two women infected in their third trimester and found that their fetuses
presented with brain abnormalities such as subependymal cysts and lenticulostriate vasculopathy
but no microcephaly (2016).
Testing Methods
The CDC has issued guidelines for ZIKV testing, Fig 1, that vary based on an
individual’s location, pregnancy status, symptoms, and exposure type. ZIKV exposure is defined
as living in, traveling to, or having sexual relations with someone recently exposed. The CDC
recommends anyone presenting Zika-like-symptoms to be tested for Zika (“Testing Guidance |
Zika Virus | CDC,” n.d.). It is advised for any male or female with possible ZIKV exposure to
avoid pregnancy for a minimum of six months or eight weeks respectively regardless of
symptoms. Pregnant women with abnormal ultrasound findings consistent with ZIKV infection
should be tested as soon as possible or within 12 weeks of symptom onset or possible exposure.
Testing for ZIKV includes both a serum ZIKV Immunoglobulin (IgM) serology and a
ZIKV nucleic acid test (NAT) on serum and urine. Cerebrospinal fluid, plasma, amniotic fluid,
tissue, and whole blood can be used for testing. Diagnosis of ZIKV can be challenging due to
cross reactivity with other flaviviruses like dengue and chikungunya. This cross reactivity may
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be overcome by using a plaque reduction neutralization test (PRNT), a serologic test to utilize
antibody properties to neutralize targeted viral samples from forming plaques on artificial
substrate. The number of observed Zika or dengue plaques helps differentiate if the infection is
due to ZIKV or another flaviviruses. However, PRNT can also give inconclusive results (Frankel
et al., 2017; “Plaque Reduction Neutralization Tests (PRNT) - LabCE.com, Laboratory
Continuing Education,” n.d.; Rabe et al., 2016; Recommendations, 2017).

Fig1: CDC testing recommendation for symptomatic pregnant women

It is not typically recommended to test asymptomatic pregnant women who are not
continuously exposed to the ZIKV. Testing should be considered on a case by case basis and
followed according to guidelines for a symptomatic pregnant woman (Recommendations, 2017).
For asymptomatic pregnant women with an ongoing ZIKV exposure, ZIKV NAT on serum and
urine three times during the pregnancy upon initiation of prenatal care is recommended. A
positive result would support an acute ZIKV infection, while a negative NAT concludes that no
ZIKV RNA was detected. However, this result does not rule out a ZIKV infection during the
pregnancy (Fig 1).
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Teratogen counseling
A healthcare provider needs to complete a thorough medical, pregnancy, and travel
history on the patient, address the patient’s concerns, look up and understand appropriate
resources, and counsel the patient. A study by Eleanor et al on the perception of physicians on
teratogenic counseling discussed barriers faced in providing teratogenic counseling. It concluded
time to be the main limiting factor (2009).
Services such as Teratogenic Information Services (TIS) and Organization of Teratology
Information Specialist (OTIS), now called Mother to Baby, are available to public and medical
professionals. Many health care providers refer patients to TIS or other specialists for teratogenic
counseling (Hancock, Ungar, Einarson, Goodstadt, & Koren, 2008). However, there are some
healthcare providers unaware of these services.
Genetic counselors (GCs), as described by National Society of Genetic Counselors
(NSGC), are trained to educate patients, assess and cater a counseling session according to
patient needs, and provide non-directive counseling. They have the flexibility to focus on these
goals and spend more time with the patient. GCs bring a skill set that is equipped with critical
thinking, problem solving, psychosocial and communication skills (Monaghan et al., 2016). The
educational requirements of the Accrediting Board of Genetic Counselors have incorporated
teratology and associated counseling techniques into the genetic counseling training curriculum
(Accreditation Council for Genetic Counseling, 2013).
Methods
The survey consisted of multiple choice, likert scale, and open-ended questions to assess
the current role, comfort, perceived knowledge, and tested knowledge of GCs in providing
prenatal ZIKV care. Personal demographics such as age, ethnicity, earned degrees, clinic
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location, specialty, years of practice, experience in providing ZIKV counseling, and personal
opinions for who should provided teratogen counseling were also collected to consider possible
correlations. The study was approved by the Sarah Lawrence College Institutional Research
Board as exempt from full review due to the nature of the data collection and targeted participant
group.
The participants were restricted to self-reported practicing GCs, determined by an initial
question that prevented non-practicing GCs from proceeding further. The link to the survey was
distributed via email by the NSGC to their member email listserv. The participants were
informed that their responses were anonymous and that by completing the survey they were
consenting to be a part of the study. The first notification was sent on a Thursday, January 25,
2018 and a reminder email was sent two weeks later. Data collection continued until February
23, 2018.
The data was downloaded from SurveyMonkey into SPSS version.24 for statistical
analysis. In the analysis of continuous variables, t-tests were used in comparing 2 groups and
One-way Anova was used for more than 2 groups. In addition to ANOVA, Tukey's Post Hoc
analysis to determine where the mean differences were when there were more than 2 groups.
Cross tabular analysis and Chi-square were used to examine the relationship between 2
categorical variables.
Results
The survey collected information on the participants’ reported comfort levels on five
areas of ZIKV care, their perceived knowledge on seven areas of ZIKV care, their years of
experience in providing ZIKV care and being a GC, the frequency of providing ZIKV care, and
the resources they use to educate themselves on ZIKV. Additionally, information on who
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provides ZIKV care and who in their opinion should provide it was also collected. This data was
compared with their responses to the four hypothetical case scenarios to assess how far their
reported responses stand true to their tested knowledge and to find any additional correlation.
Basic demographic information was also collected.
Sample Demographics
Overall, 58 practicing GCs covering 28 different states and Washington D.C. in the
United States completed the survey. See Table 1 for demographic information.
GC role in ZIKV counseling
41 (71%) of the respondents reported prior experience in providing prenatal ZIKV
counseling. Of these 41 respondents, 18 (30%) reported counseling 1-5 ZIKV patients in total,
11 (19%) reported counseling 1-5 per year, 10 (17%) reported counseling 1-5 per month, 3 (5%)
reported counseling 1-5 per week, 1 (2%) reported counseling 1-5 per day and 15 (26%) reported
not applicable.
31% (18) of the respondents indicated that GCs provide ZIKV care at their site, 12% (7)
reported a collaborative approach between GCs and other healthcare providers, 40% (23)
reported that other healthcare providers provide the counseling, and 17% (10) were unsure.
However, when asked who they think should provide ZIKV counseling, 20% (11) indicated GCs,
3% (2) indicated GCs plus other healthcare providers, and 12% (7) were unsure; these
percentages are decreased in relation to current practice. Conversely, the percentage of
respondents who indicated that other healthcare providers are the ideal professionals to provide
ZIKV counseling increased to 65% (38). These other providers included maternal fetal medicine
specialist (MFM; 29, 76%), general OB/GYN (8, 21%), and Infectious Diseases specialists (1,
2%).
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Table 1: Participants’ Demographics
Number of Participants

N=58

Sex of GCs
Females
Males

56
2

Ethnicity
Caucasian
Asian
Hispanic/Latino

53
3
2

Age Range
20 - 30
31 - 40
41 - 50
51 - 60
60+

33
13
9
1
2

Years of experience
<1
1-5
6-10
11-20
21-30
31-40

7
29
9
9
3
1

Workplace Setting
University medical center
Private/Public hospital
Private practice
Laboratory
Telehealth

Specialization of participant
Prenatal
Pediatric
Multiple specialties
Other

29
20
7
1
1
31
5
14
8

Clinic Setting
Urban
Suburban
Rural

39
18
1

Reported Education
MS in Genetic counseling or human genetics
Additional Masters degree
Additional Ph.D.

58
6
1
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Table 1: The survey collected patient demographics to enable further correlations with the GC’s reported knowledge, tested knowledge, reported comfort level,
their role in providing ZIKV care in their clinic and who in their opinion should provide this care.

Table 2: Self reported knowledge on seven areas of ZIKV care
Areas
with Modes
of Symptoms Zika
ongoing ZIKV transmission of ZIKV testing
transmission
of ZIKV
infection
methods

Interpretation
of results

Features
of CZS

Risk
for
fetus to have
CZS

No
Knowledge

3.45% (2)

0% (0)

1.72% (1)

12.07%
(7)

17.24% (10)

0% (0)

8.62% (5)

Limited
Knowledge

70.69% (41)

50% (29)

51.72%
(30)

65.52%
(38)

67.24% (9)

55.17%
(32)

68.97% (40)

Expert/
Significant
knowledge

25.86% (15)

50% (29)

46.55%
(27)

22.41%
(13)

15.52% (9)

44.83%
(26)

22.41% (13)

Table 3: Reported comfort levels based on five areas of ZIKV care
Chance the
patient had
ZIKV infection

Chance the fetus
is/would be
affected with
CZS

Features of CZS

Options for
further
evaluation

Pregnancy
termination
ZIKV exposure

Not Comfortable

13.79% (8)

12.07% (7)

8.62% (5)

15.52% (9)

13.79% (8)

Somewhat
uncomfortable /
Unsure

34.48% (20)

43.10% (25)

29.31% (17)

29.31% (17)

32.76% (19)

Comfortable

51.72% (30)

44.83% (26)

62.07% (6)

55.17% (32)

53.45% (31)

Table 4: Tested knowledge using four board style case scenarios
Scenario 1

Scenario 2

Scenario 3

Scenario 4

Correct

29.31% (17)

87.93% (51)

32.76% (19)

17.24% (10)

Incorrect

17.24% (10)

1.72% (1)

12.07% (7)

53.45% (31)

Not sure

53.45% (31)

10.34% (6)

55.17% (32)

29.31% (17)

Table 5: Correlation of number of years of practice and reported comfort levels
Chance the
patient had the
ZIKV infection

Chance the fetus
is/would be
affected with

Features of CZS

Options for
Further
Evaluation

Pregnancy
termination due
to Zika exposure
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R(58)

.28, p< .05

CZS
.31, p< .01

.24, p< .05

.32, p< .01

.21, p<.05

Fig 2: Comparison of reported comfort levels and tested knowledge by four different case scenarios

Fig 3: Comparison of comfort levels based on Zika counseling experience

Fig 4: Correlation of experience providing Zika care and knowledge tested
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Fig 5: Comparison of comfort levels by the Zika care provider

Fig 6: Correlation between reported knowledge and report comfort levels

Fig 7: Association of years of experience in genetic counseling to perceived knowledge

Tested knowledge
Participants were presented with four clinical scenarios and were asked to answer boardsstyle questions to assess their knowledge regarding testing and counseling strategies (See table
4). Overall, only three participants chose the right answers to all the four scenarios.
Reported comfort levels and correct responses
In relation to the comfort levels for discussing ZIKV matters on the four case scenarios,
there were significant differences for all the five comfort areas (Fig 2). One-way ANOVA was
conducted and all F values were statistically significant (Fig 2). However, in every case, Tukey’s
Post Hoc analysis revealed the difference was in the comfort levels between those who were
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unsure and those who had either the correct or the incorrect answer. The mean comfort levels of
those with incorrect responses were as high as those with correct responses and often higher.
Reported knowledge and correct answer
In relation to the GCs’ knowledge of ZIKV matters on the four case scenarios, there were
significant differences for most of the seven knowledge areas by their answers. One-way
ANOVA was conducted, except for case number two, where only one person who had the
incorrect answer and only two categories and a t-test was used.
For case number one and three, all F values were statistically significant. Case number
four, had six out of seven areas of knowledge were statistically significant and case number
three, had five out of seven areas were statistically significant. However, in every case, Tukey’s
Post Hoc analysis revealed the difference was in the knowledge levels between those who
reported unsure and those who had either the correct or the incorrect answer. The mean
knowledge levels of those with incorrect responses were as high as those with correct responses
and often higher. Participants unsure of their answers had lower perceived knowledge levels that
were statistically significant.
Experience
The comfort level discussing all areas of ZIKV was positively correlated with how long
GCs have been in practice. However, having counseled a ZIKV patient was not associated with
years of experience. In addition, years in practice did not correlate with correct answers on the
four cases scenarios.
GCs with ZIKV counseling experience had significantly higher comfort levels than those
who had not (Fig 3). They were also more comfortable in all five areas. The mean scores for
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those who had counseled a patient were usually around 4.00 or “Somewhat comfortable,” while
those without experience had mean scores around 2.00 or “Somewhat uncomfortable.”
Three of the four cases showed significant differences where GCs with prior ZIKV
counseling experience had more correct answers than those without (Fig 4). In the case of
scenario 1, 36.6% (15) of those with experience had a correct answer while only 11.8% (2)
without experience answered correctly (Chi-square = 3.57 (df=1), p<.05). For scenario 2, 95.1%
(39) of those with ZIKV counseling experience had the correct answer, while only 70.6% (12) of
those without experience answered correctly (Chi-square = 6.82 (df=1), p<.01). For scenario 3,
46.3% (19) of those with ZIKV experience had the correct answer and for those without did not
have a correct answer (Chi-square = 11.72 (df=1), p<.01). The only difference that was not
statistically significant was for scenario 4. 19.5% (8) of those with experience answered
correctly, and 16.8% (2) without experience answered correctly (Chi-square = .51 (df=1), n.s.).
Perceived Knowledge based analysis
The GCs’ perceived knowledge about all seven areas of Zika was positively correlated
with years of practice (Fig 7). This includes knowledge about areas of ongoing ZIKV
transmission (r (58) = .29, p<.05), modes of transmission of the ZIKV (r (58) = .22, p<.05),
symptoms of ZIKV infection (r (58) = .30, p<.05), Zika testing methods (PCR,lgM,PRNT) (r
(58) = .23, p<.05), the interpretation of results (r (58) = .25, p<.05), features of CZS (r (58) = .40,
p< .01), and the risk for fetus to have CZS (r (58) = .37, p< .01).
There were strong positive correlations between the GCs’ comfort in discussing certain
issues about ZIKV and their ratings of their knowledge in all areas of ZIKV information (Fig 6).
Being comfortable discussing the chance the patient has a ZIKV infection correlated with
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knowledge of areas with ongoing ZIKV transmission (r (58) = .68, p<.001), modes of
transmission of ZIKV (r (58) = .58, p<.001), symptoms of ZIKV infection (r (58) =.60, p<.001),
ZIKV testing methods (r (58) = .61, p<.001), interpretation of results (r (58) = .64, p<.001),
features of CZS (r (58) = .51, p< .001), and risk for the fetus to have CZS (r (58) = .56, p<.001).
Being comfortable discussing the chance the fetus is/would be affected with CZS
correlated with knowledge of areas of ongoing ZIKV transmission (r (58) = .64, p<.001), modes
of transmission of the ZIKV (r (58) .51, p<.001), symptoms of ZIKV infection (r (58) =.60,
p<.001), ZIKV testing methods (r (58) = .60, p<.001), interpretation of results (r (58) = .74,
p<.001), features of CZS (r (58) = .61, p< .001), and risk for the fetus to have CZS (r (58) = .67,
p<.001).
Comfort discussing the features of CZS was correlated with knowledge of areas of
ongoing ZIKV transmission (r (58) = .55, p<.001), modes of transmission of the ZIKV (r (58)
.59, p<.001), symptoms of ZIKV infection (r (58) =.64, p<.001), Zika testing methods (r (58) =
.54, p<.001), interpretation of positive, negative and inconclusive results (r (58) = .69, p<.001),
features of CZS (r (58) = .70, p< .001), and risk for the fetus to have CZS (r (58) = .66, p<.001).
Comfort discussing options for further evaluation was correlated with knowledge of areas
of ongoing ZIKV transmission (r (58) = .60, p<.001), modes of transmission of the ZIKV (r (58)
.62, p<.001), symptoms of ZIKV infection (r (58) =.64, p<.001), Zika testing methods (r (58) =
.62, p<.001), interpretation of positive, negative and inconclusive results (r (58) = .74, p<.001),
features of CZS (r (58) = .72, p< .001), and risk for the fetus to have CZS (r (58) = .72, p<.001).
Comfort discussing pregnancy termination from ZIKV exposure was correlated with
knowledge of areas of ongoing ZIKV transmission (r (58) = .59, p<.001), modes of transmission
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of the ZIKV (r (58) .53, p<.001), symptoms of ZIKV infection (r (58) =.54, p<.001), Zika testing
methods (r (58) = .58, p<.001), interpretation of positive, negative and inconclusive results (r
(58) = .60, p<.001), features of CZS (r (58) = .58, p< .001), and risk for the fetus to have CZS (r
(58) = .51, p<.001).
ZIKV Care provider
Analysis of comfort levels by who provides counseling for ZIKV indicated that when it
was the GC alone versus the GC plus other healthcare professionals versus other healthcare
professionals, there were significant differences in comfort levels (Fig 5). The GC alone always
had significantly higher comfort levels than the GC plus other healthcare professionals or other
healthcare professionals. GCs had higher comfort levels in all five areas, the chance the patient
had the ZIKV infection, the chance the fetus would be affected with CZS, the features of ZIKV,
the options for further evaluation, and pregnancy termination from ZIKV exposure. Four out five
categories of comfort levels have a p<0.01 and except comfort discussing pregnancy termination
from ZIKV exposure has a significance of p<0.5.
Resources Used
In the case scenario 1, GCs who used a state or local Department of Health (DOH) source
were more likely to have a correct answer, 38.7% (12) for those who used this source versus
18.5% (5) for those who did not. Most of those who did not use this source, 70.4% (19) were
unsure of the answer, while only 38.7% (12) of those who used it were unsure of the correct
response. (Chi-square = 5.82, (df=2) p<.05). The use of PubMed or other literature searches also
had significant differences in this case (Chi-square = 5.42, (df=1), p<.05). 52.2% (12) of those
who used PubMed or another literature search and only 20.0% (5) of those who did not use it
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chose the correct answer. 80.0% (20) of those not using it and 47.8% (11) of those who used it
were unsure of the answer.
In the case scenario 2, 40.2% (28) of those using PubMed or another literature search had
the correct answer, while 76.7% (23) of those who did not use these sources had the correct
answer (Fisher’s exact p <.05). All seven respondents who were unsure or had an incorrect
answer did not use these sources.
In case scenario 3, respondents who used PubMed or another literature search were more
likely, 52.0% (13), to have the correct answer than the 23.1% (6) who did not use these sources.
76.9% (20) of those who did not use these sources were unsure of the answer, while only 48.0%
(12) of those who did not use PubMed or another literature search were unsure of the answer
(Chi-square = 4.50 (df=1) p<.05).
Discussion
The goal of the study was to assess the current and potential role of GCs in providing
ZIKV care. This was assessed by analyzing their comfort levels, perceived knowledge, tested
knowledge via 4 case scenarios, their years of experience in the field of genetic counseling, and
their experience in providing ZIKV care. Additionally, the participants were asked who provides
ZIKV care at their site and whom they think should ideally provide this care. Comparisons and
correlations were made to verify the reported responses.
The participants were asked to rate their comfort levels with respect to 5 areas of ZIKV
counseling and the weighted average was 3.29 on a scale of 5. Comparing their individual
responses to the comfort level and the 4 case scenarios revealed even though GCs may be
comfortable with ZIKV counseling, their knowledge of what to do can be faulty. Their reported
comfort does not always reflect proper understanding of the subject. With half of the participants
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having 1-5 years of experience, the data supports a higher comfort level for GCs with more
ZIKV genetic counseling experience. This shows that participants with more experience feel
more confident in their abilities to counsel patients on relatively new topics, like ZIKV.
However, years in practice was not correlated correct responses to the four cases. A GC’s ability
to identify appropriate resources and the prior availability of patient medical information,
including ultrasound findings, for case preparation could be attributed to this trend. For instance,
25 to 30% of the participants, who reported CDC, DOH and/or PubMed and other literature as
their primary resources chose the correct response to at least two case scenarios. It also shows
that GCs are able to properly research topics of interest they may not have previous experience in
counseling.
Although Accreditation Council for Genetic Counseling requires GCs to be trained for
teratogen counseling, the survey indicated a drop from 52% (30) of GCs providing teratogen
counseling to 31% (18) of GCs providing ZIKV care. This could infer GCs though trained to
provide counseling for typical teratogens are not as comfortable with new teratogens.
Additionally, 65% (38) of the participants thought ZIKV counseling should be provided by other
healthcare providers. This could be because ZIKV is a relatively new teratogen that is not
genetic. This calls for more guidance/recommendations/coordination among specialties on
national and institutional levels supporting the need for multidisciplinary care for emerging
issues.
The weighted average of participants’ perceived knowledge about all seven areas of
ZIKV was 3.12. It positively correlated with how long they have been in practice. When
analyzing the perceived knowledge compared to tested knowledge, the mean knowledge levels
of those with incorrect responses were as high as those with correct responses, and often even
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higher. This indicates that counselors can rate themselves as knowledgeable in discussing ZIKV
issue with their patients but their knowledge of what to do can be incorrect. This supports a
stronger need for new teratogen education for health care providers.
Examining responses to the four case scenarios by whether or not GCs had counseled a
ZIKV patient, three of the four cases showed significant differences. Those who had counseled
patients had more correct answers, and significantly higher comfort levels than counselors who
had no prior ZIKV counseling experience. This supports a stronger association for case specific
experience to correlate to higher comfort and knowledge levels for GCs regardless of their years
of experience, which is also found to have no association through the survey. This makes sense
since ZIKV is a relatively new development and individuals with prior ZIKV experience would
have done research to prepare for the case.
Significant differences were found when comparing accurate knowledge of GCs who
have previously counseled patients regarding the ZIKV to GCs without previous experience. The
responses to the four case scenarios were not related to who provided counseling on ZIKV at the
center. However, there was a relationship between who provided the counseling at the center and
who the respondents thought should provide the counseling (Fishers exact p<.01). All of the
institutions (10) where the MFM provided counseling on ZIKV risks thought that the MFM
should provide the counseling. When GCs provided the counseling, 53.9% (7) thought GCs
should do the counseling, while 46.2% (6) thought the MFM should do the counseling. Analysis
of comfort levels by who provides counseling for ZIKV indicated that when it was the GC alone
versus the GC plus other healthcare professionals versus other healthcare professionals, there
were significant differences in comfort levels (Fig 7). The GC alone always had significantly
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higher comfort levels than the GC plus other healthcare professionals or other healthcare
professionals.
Study Limitations
It is a self-reported study that targeted all practicing GCs irrespective of their prior
experience in providing ZIKV counseling. This could have resulted in biased reporting of their
knowledge and comfort levels leading to skewed data analysis. Credential verification was not
required to participate in the survey. Although the case scenarios were used to access their
knowledge, the scenarios were limited both in number and breadth of knowledge. The
knowledge assessment was computed from four hypothetical ZIKV case scenarios, three of
which focused on testing protocols for ZIKV related occurrences. When assessing comfort,
perceived knowledge and tested knowledge, there was no consistency in the topics assessed. This
would have enabled better and consistent correlation analysis.
This study is unique in itself without similar literature. However, it limits the results
found due to the inability to compare the findings.
The sample size was small with 58 surveys completed, even though 85 individuals
opened the survey yielding a 68% completion rate. The introductory email stated an estimated
length of time to complete the survey as 15-20 minutes; however, Surveymonkey reported 4
mins as the average time individuals spent. This could have swayed individuals with a busy work
life schedule from participating in the survey. Motivation to participate in the survey may have
deterred further by lack of incentives such as gift cards.
ZIKV infections and its teratogenic nature is a relatively new topic and the frequency in
the United States is not uniform throughout the country. This could have contributed to incorrect
responses to the case scenarios, and the discrepancies in higher numbers of GCs being involved
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in teratogen counseling than ZIKV counseling. Additionally, in the case of scenario 4, a couple
of respondents requested clarification. This could have contributed to less respondents choosing
the right answer.
Practice Implications
This study highlights the importance of education and communication regarding
emerging counseling issues. Increasing awareness of the available resources and providing
training with the identification of every new teratogen may boost confidence of GCs and expand
their knowledge of approved protocols. Utilizing services such as OTIS when GCs or other
health care providers are unsure or uncomfortable providing ZIKV care can ensure better service.

Research Recommendations
This study requires consistent metrics to assess the comfort and knowledge of GCs. To
ensure better assessment of knowledge it is important to present case scenarios covering a broad
spectrum of GCs role in ZIKV care. Pre and post educational surveys may better assess
understanding and management of hypothetical case scenarios. Expanding the sample size may
obtain stronger significance and better reflect the targeted population.
Conclusion
This study revealed GCs with experience are comfortable providing ZIKV counseling.
This comfort, however, does not necessarily reflect their tested knowledge. This may be
overcome by further training and increasing the availability and awareness of reliable resources.
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